Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Treasury Shares (2018 - 2025)

Black Diamond Therapeutics' Treasury Shares history spans 5 years, with the latest figure at $450000.0 for Q4 2025.

  • For Q4 2025, Treasury Shares fell 16.67% year-over-year to $450000.0; the TTM value through Dec 2025 reached $450000.0, down 16.67%, while the annual FY2025 figure was $450000.0, 16.67% down from the prior year.
  • Treasury Shares reached $450000.0 in Q4 2025 per BDTX's latest filing, down from $670000.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $990000.0 in Q1 2025 to a low of $19000.0 in Q1 2024.
  • Average Treasury Shares over 3 years is $349901.2, with a median of $254669.0 recorded in 2021.
  • Peak YoY movement for Treasury Shares: tumbled 48.31% in 2021, then skyrocketed 5110.53% in 2025.
  • A 3-year view of Treasury Shares shows it stood at $30667.0 in 2021, then surged by 1660.85% to $540000.0 in 2024, then decreased by 16.67% to $450000.0 in 2025.
  • Per Business Quant, the three most recent readings for BDTX's Treasury Shares are $450000.0 (Q4 2025), $670000.0 (Q3 2025), and $670000.0 (Q2 2025).